HHS Public Access Author manuscript Author Manuscript
Clin Transplant. Author manuscript; available in PMC 2017 January 28. Published in final edited form as: Clin Transplant. 2016 September ; 30(9): 1036–1045. doi:10.1111/ctr.12785.
Patient-Reported Outcomes in Liver Transplant Recipients with Hepatocellular Carcinoma Clark D. Kensinger1,2, Irene D. Feurer1,2,3, Heather W. O'Dell2, David C. LaNeve2, Lindsey Simmons2, C. Wright Pinson1,2, and Derek E. Moore1,2 1Department
Author Manuscript
2Vanderbilt
of Surgery, Vanderbilt University Medical Center
Transplant Center
3Department
of Biostatistics, Vanderbilt University scholl of Medicine
Abstract Background—The effect of awarding MELD exception points for Hepatocellular Carcinoma (HCC) on patient-reported outcomes (PROs) is unknown. We evaluated the physical and mental health-related quality of life (HRQOL), and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC. Methods—The single-center sample measured PROs before and post-transplant, which included 1,521 multi-survey measurement points among 502 adults (67% male, 28% HCC, follow-up time:
Clin Transplant. Author manuscript; available in PMC 2017 January 28. Published in final edited form as: Clin Transplant. 2016 September ; 30(9): 1036–1045. doi:10.1111/ctr.12785.
Patient-Reported Outcomes in Liver Transplant Recipients with Hepatocellular Carcinoma Clark D. Kensinger1,2, Irene D. Feurer1,2,3, Heather W. O'Dell2, David C. LaNeve2, Lindsey Simmons2, C. Wright Pinson1,2, and Derek E. Moore1,2 1Department
Author Manuscript
2Vanderbilt
of Surgery, Vanderbilt University Medical Center
Transplant Center
3Department
of Biostatistics, Vanderbilt University scholl of Medicine
Abstract Background—The effect of awarding MELD exception points for Hepatocellular Carcinoma (HCC) on patient-reported outcomes (PROs) is unknown. We evaluated the physical and mental health-related quality of life (HRQOL), and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC. Methods—The single-center sample measured PROs before and post-transplant, which included 1,521 multi-survey measurement points among 502 adults (67% male, 28% HCC, follow-up time:
